https://european-biotechnology.com/wp-content/uploads/2024/04/RS5629_AdobeStock_127114772-scr.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-21 09:30:422024-07-12 12:49:16Minaris and LIfT BioSciences collaborate in cell therapy development
France-based Abivax SA announced the appointment of Sheldon Sloan, M.D., M. Bioethics, as its new Chief Medical Officer. He will assume the new role in the beginning of March.
PVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre.
A UK Biobank study suggests that higher intake of free sugars is associated with a higher risk to develop cardiovascular disease, UK researchers report in BMC Medicine.
https://european-biotechnology.com/wp-content/uploads/2024/04/Expansion_of_the_Munich.png540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-15 10:42:062024-06-21 14:05:29Expansion of the Munich science line has started
Fermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-02-14_um_17.00.23.png459971Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-15 06:01:002024-07-15 12:38:25AMsilk scaling up through Evonik collaboration
Cambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-02-13_um_09.42.45.png366713Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-13 09:24:042024-04-04 16:44:47Cydar Medical Ltd raises €10.5m in Series A financing
British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.
https://european-biotechnology.com/wp-content/uploads/2024/04/evonteix-home-silicon-array.jpeg571800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-07 17:13:432024-07-15 12:58:38Evonetix extends Series B financing to US$54m
Minaris and LIfT BioSciences collaborate in cell therapy development
Latest NewsCDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences.
Abivax appoints new CMO
AppointmentsFrance-based Abivax SA announced the appointment of Sheldon Sloan, M.D., M. Bioethics, as its new Chief Medical Officer. He will assume the new role in the beginning of March.
PVH Corp joins fiber-to-fiber consortium
Latest NewsPVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre.
Free sugar linked to higher cardiovascular disease
Latest NewsA UK Biobank study suggests that higher intake of free sugars is associated with a higher risk to develop cardiovascular disease, UK researchers report in BMC Medicine.
Expansion of the Munich science line has started
BackgroundThe extension, which was celebrated with an official groundbreaking ceremony, will connect the IZB campus in Martinsried to the Munich subway system.
AMsilk scaling up through Evonik collaboration
Latest NewsFermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins.
HOOKIPA bags US$10m cancer milestone
Latest NewsHOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers.
Cydar Medical Ltd raises €10.5m in Series A financing
Latest NewsCambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust
Upping sustainability in pharma packaging
Latest NewsHow to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023.
Evonetix extends Series B financing to US$54m
Latest NewsBritish Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.